跳转至内容
Merck
CN

74723

1-十八醇

Selectophore, ≥99.0%

别名:

十八烷醇, 硬脂醇

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
CH3(CH2)17OH
化学文摘社编号:
分子量:
270.49
UNSPSC Code:
26111700
NACRES:
NA.05
PubChem Substance ID:
EC Number:
204-017-6
Beilstein/REAXYS Number:
1362907
MDL number:
Assay:
≥99.0% (GC), ≥99.0%
Form:
pellets
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


vapor density

9.3 (vs air)

Quality Level

vapor pressure

<0.01 mmHg ( 38 °C)

description

for ion-selective electrodes

product line

Selectophore

assay

≥99.0% (GC), ≥99.0%

form

pellets

autoignition temp.

842 °F

expl. lim.

~8 %

mp

56-59 °C (lit.)

solubility

THF: 1 g/10 mL, clear, colorless

density

0.812 g/mL at 25 °C (lit.)

SMILES string

CCCCCCCCCCCCCCCCCCO

InChI

1S/C18H38O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3

InChI key

GLDOVTGHNKAZLK-UHFFFAOYSA-N

General description

请访问我们的 传感器应用页面 以了解更多信息。

Legal Information

Selectophore is a trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under 1-十八醇


存储类别

11 - Combustible Solids

wgk

nwg

flash_point_f

383.0 °F - closed cup

flash_point_c

195 °C - closed cup

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



M D Koone et al.
Archives of dermatology, 126(11), 1485-1490 (1990-11-01)
A number of inherited disorders of cornification have been related to abnormal lipid metabolism. In the recessively inherited Sjögren-Larsson syndrome, defined by the triad of ichthyosis, mental retardation, and spasticity, fatty alcohol:NAD+ oxidoreductase deficiency has recently been reported. These patients
Jin-Ki Kim et al.
ACS nano, 5(1), 209-216 (2010-12-17)
Nanocarrier systems are frequently characterized by their size distribution, while drug encapsulation in nanocarriers is generally characterized in terms of an entire population, assuming that drug distribution is uniform. Careful characterization of nanocarriers and assessment of their behavior in biological
Akhtar Siddiqui et al.
International journal of pharmaceutics, 431(1-2), 222-229 (2012-05-09)
The objective of this study was to increase the potency of doxorubicin against adriamycin-resistant NCI/ADR-RES cells by concurrent treatment with doxorubicin and MBO-asGCS loaded solid-lipid nanoparticles (SLN). Loading doxorubicin as ion-pair complex with deoxytaurocholate into cationic and neutral SLN was



全球贸易项目编号

货号GTIN
1018505-200MG04061833839652
A1260-100G04061833341988
A1260-5G04061833342008
PHR1711-500MG04061834801900
A1260-25G04061833341995
A036300004061833327814
820015001004022536450353
820015005004022536450360
74723-1G04061826651926
74723-5G04061833354711